Gelatinous Capsules of β-Lapachone for Anti-cancer Therapies

被引:0
|
作者
Presmich, Geisiane M. A. [1 ]
Rolim, Larissa A. [1 ]
Medeiros, Flavia P. M. [1 ,3 ]
Albuquerque, Miracy M. [2 ]
Rolim-Neto, Pedro J. [1 ]
机构
[1] Univ Fed Pernambuco, Lab Tecnol Medicamentos, Dept Ciencias Farmaceut, BR-50740521 Recife, PE, Brazil
[2] Univ Fed Pernambuco, NCQMC, BR-50740521 Recife, PE, Brazil
[3] Lab Farmaceut Estado Pernantbuco LAFEPE Largo de, BR-52171010 Recife, PE, Brazil
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2010年 / 29卷 / 05期
关键词
beta-lapachone; soft gelatinous capsules and hard; stability; PROSTATE-CANCER CELLS; MEDIATED APOPTOSIS; DERIVATIVES; INHIBITION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
"Gelatinous Capsules of beta-Lapachone for Anti-cancer Therapies". beta-lapachone is a natural ortonaftoquinona of ipe purple growing mainly in Brazil, also obtained by the process of semi-synthesis of its isomer lapachol. It is a simple plant product that has demonstrated excellent potential in antineoplastic studies in albino rats, mice and cell cultures. Works by a particular mechanism of apoptosis against various types of cancer, especially some strains of prostate refractory to conventional treatments. It has low solubility in water, the development of a pharmaceutical form the basis of beta-lapachone providing favorable bioavailability is a key point for the continuity of research with this asset. Hard gelatine capsules containing 250 mg of beta-lapachone and soft gelatine capsules containing 30 mg beta-lapachone were developed. Due to the crystalline form and character of lipophilic beta-lapachone, the hard gelatin capsules did not show acceptable levels of dissolution, however, the soft gelatinous capsules showed satisfactory results for continuation of studies in this active.
引用
收藏
页码:674 / 680
页数:7
相关论文
共 50 条
  • [21] Carboranylporphyrazines for anti-cancer therapies: synthesis and physicochemical properties
    Pietrangeli, Daniela
    Ristori, Sandra
    Rosa, Angela
    Ricciardi, Giampaolo
    JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2010, 14 (08) : 678 - 688
  • [22] Recent advances in platelet engineering for anti-cancer therapies
    Lv, Yanlin
    Wei, Wei
    Ma, Guanghui
    PARTICUOLOGY, 2022, 64 : 2 - 13
  • [23] Telomere and telomerase as targets for anti-cancer and regeneration therapies
    Yi-hsin Hsu
    Jing-jer Lin
    Acta Pharmacologica Sinica, 2005, 26 : 513 - 518
  • [24] Synthesis of anti-cancer targeted therapies drug tivozanib
    Liu, Mingxing
    Hu, Lixiu
    Wang, Xianwen
    Zhu, Hongda
    ADVANCES IN CHEMICAL ENGINEERING, PTS 1-3, 2012, 396-398 : 1490 - 1492
  • [25] New anti-cancer therapies, new opportunities for infection
    Potter, M
    CURRENT OPINION IN INFECTIOUS DISEASES, 1999, 12 (04) : 359 - 363
  • [27] Oncolytic animal viruses and their applications in anti-cancer therapies
    Chodkowski, Marcin
    Cymerys, Joanna
    Slonska, Anna
    Banbura, Marcin W.
    MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2017, 73 (01): : 4 - 9
  • [28] The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies
    Nguyen, Dao M.
    Hussain, Mustafa
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2007, 39 (01) : 13 - 21
  • [29] Anti-Cancer Therapies that Utilize Cell Penetrating Peptides
    Bitler, Benjamin G.
    Schroeder, Joyce A.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (02) : 99 - 108
  • [30] New anti-cancer strategies: Epigenetic therapies and biomarkers
    Balch, C
    Montgomery, JS
    Paik, HI
    Kim, S
    Huang, THM
    Nephew, KP
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 1897 - 1931